E5531

Star0

DB06447ExperimentalSmall molecule

E5531 is an endotoxin antagonist.

Primary indication: Investigated for use/treatment in sepsis and septicemia.Curator reviewed
Formula / weight: C₇₃H₁₃₆N₂O₂₂P₂ · 1455.831 g/mol (avg)
Code names: E-5531

Resolves to

Compound

UNII4468VT5E70CAS162679-36-9

Structure

InChIKeyGDODKYPBSZCPOO-XFMGTHRKSA-NSMILES

[H]N([C@H]1[C@@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC(=O)CCC\C=C/CCCCCC)[C@H]2N([H])C(=O)CC(=O)CCCCCCCCCCC)[C@@H](O)[C@@H]1OCC[C@H](O)CCCCCCC)C(=O)CC(=O)CCCCCCCCCCC

Targets

O00206TLR4

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with E5531, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account